Xortx Therapeutics Stock Market Value
| XRTX Stock | 1.73 0.15 7.98% |
| Symbol | XORTX |
XORTX Therapeutics Price To Book Ratio
XORTX Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XORTX Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XORTX Therapeutics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in XORTX Therapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding XORTX Therapeutics or generate 0.0% return on investment in XORTX Therapeutics over 30 days. XORTX Therapeutics is related to or competes with Sernova Corp. XORTX Therapeutics is entity of Canada. It is traded as Stock on V exchange. More
XORTX Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XORTX Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XORTX Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.72 | |||
| Information Ratio | 0.0452 | |||
| Maximum Drawdown | 160.18 | |||
| Value At Risk | (12.64) | |||
| Potential Upside | 12.31 |
XORTX Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XORTX Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XORTX Therapeutics' standard deviation. In reality, there are many statistical measures that can use XORTX Therapeutics historical prices to predict the future XORTX Therapeutics' volatility.| Risk Adjusted Performance | 0.0498 | |||
| Jensen Alpha | 0.6592 | |||
| Total Risk Alpha | (1.92) | |||
| Sortino Ratio | 0.0942 | |||
| Treynor Ratio | 0.4019 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of XORTX Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
XORTX Therapeutics Backtested Returns
XORTX Therapeutics is out of control given 3 months investment horizon. XORTX Therapeutics shows Sharpe Ratio of 0.065, which attests that the company had a 0.065% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.21% are justified by taking the suggested risk. Use XORTX Therapeutics Downside Deviation of 8.72, mean deviation of 7.19, and Market Risk Adjusted Performance of 0.4119 to evaluate company specific risk that cannot be diversified away. XORTX Therapeutics holds a performance score of 5 on a scale of zero to a hundred. The firm maintains a market beta of 2.34, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, XORTX Therapeutics will likely underperform. Use XORTX Therapeutics maximum drawdown, semi variance, accumulation distribution, as well as the relationship between the potential upside and skewness , to analyze future returns on XORTX Therapeutics.
Auto-correlation | 0.02 |
Virtually no predictability
XORTX Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between XORTX Therapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XORTX Therapeutics price movement. The serial correlation of 0.02 indicates that only 2.0% of current XORTX Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.02 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
XORTX Therapeutics lagged returns against current returns
Autocorrelation, which is XORTX Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XORTX Therapeutics' stock expected returns. We can calculate the autocorrelation of XORTX Therapeutics returns to help us make a trade decision. For example, suppose you find that XORTX Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XORTX Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XORTX Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XORTX Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XORTX Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
XORTX Therapeutics Lagged Returns
When evaluating XORTX Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XORTX Therapeutics stock have on its future price. XORTX Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XORTX Therapeutics autocorrelation shows the relationship between XORTX Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in XORTX Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.